comparemela.com

Latest Breaking News On - Other otc endv - Page 1 : comparemela.com

Endonovo Pending Agreement to Develop Telehealth Division

Los Angeles, CA, June 07, 2023 (GLOBE NEWSWIRE) Endonovo Therapeutics, Inc. (OTCQB: ENDV), an industry leading medical technology company, is working.

Ira weisbergLos angelesGregorya mcandrewsEndonovo sofpulseAlan collierSteve barnesGreg mcandrews associatesTelehealth divisionExchange commissionEndonovo telehealth divisionEndonovo therapeutics incMedical divisionStrategic partnershipsTelehealth marketExpansion opportunitiesPulsed electro magnetic field

Endonovo Announces Distribution Agreement with Academy

Provide Improved Medical Services to VHA and U.S. Dept. of Defense Los Angeles, CA, March 06, 2023 (GLOBE NEWSWIRE) Endonovo Therapeutics, Inc..

United statesWest palm beachWest pointSteve barnesEndonovo sofpulseLos angelesJohn campbellIra weisbergGregorya mcandrewsDepartment of defenseEndonovo therapeutics incEndonovo medical device divisionVeterans health administrationUs department of veterans affairsSofpulse incAcademy medical dept

Endonovo Partners with International Distributor for

Partnership Expected to Increase SofPulse® Distribution and Revenues Los Angeles, CA, Jan. 26, 2023 (GLOBE NEWSWIRE) Endonovo Therapeutics, Inc..

United statesCosta ricaSteve barnesLos angelesIra weisbergGregorya mcandrewsInternational expansionEvermed medical enterprise ltdEndonovo therapeutics incPartnership expected to increase sofpulseExchange commissionPulse therapeutics technology incSofpulse incGreg mcandrews associatesPartnership expectedPulse therapeutics technology

Endonovo Therapeutics Details Plan to Spin Off Medical

Los Angeles, CA, Jan. 09, 2023 (GLOBE NEWSWIRE) Endonovo Therapeutics Inc. (OTCQB: ENDV) today announced details for its plan to spin off its current.

Steve barnesLos angelesIra weisbergAlan collierGregorya mcandrewsExchange commissionHead of corporate development garry michael kannDepartment of defenseEndonovo therapeutics incGreg mcandrews associatesChief commercial officerCorporate development garry michael kannEndonovo therapeuticsBuild up strategyPrivate securities litigation reform actRelations contact

Endonovo Names Ira Weisberg President to Guide Global

Los Angeles, CA, Nov. 30, 2022 (GLOBE NEWSWIRE) Endonovo Therapeutics, Inc. (OTCQB: ENDV) today named Ira Weisberg as President and Chief Commercial.

United statesSteve barnesLos angelesAlan collierNeurotrope bioscienceGregorya mcandrewsExchange commissionAmherst pharmaceuticalsCe european unionCorporate developmentEndonovo therapeutics incGreg mcandrews associatesIra weisbergChief commercial officerPulsed electro magnetic frequencyCorporate development officer

vimarsana © 2020. All Rights Reserved.